BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang D, Du Y, Xu H, Pan H, Wang R. Paeonol protects mitochondrial injury and prevents pulmonary vascular remodeling in hypoxia. Respir Physiol Neurobiol 2019;268:103252. [PMID: 31301382 DOI: 10.1016/j.resp.2019.103252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Su XL, Bai TT, Qin W, Li AH, Liu YX, Wang M, Wang JK, Xing L, Li HJ, He CX, Zhou X, Zhao D, Li PQ, Wu SP, Liu JL, Chen YL, Cao HL. New paeonol derivative C302 reduces hypertension in spontaneously hypertensive rats through endothelium-dependent and endothelium-independent vasodilation. Eur J Pharmacol 2022;927:175057. [PMID: 35636525 DOI: 10.1016/j.ejphar.2022.175057] [Reference Citation Analysis]
2 Li J, Zhang G, Yin D, Li Y, Zhang Y, Cheng J, Zhang K, Ji J, Wang T, Jia Y, Yin S. Integrated application of multi-omics strategies provides insights into the environmental hypoxia response in Pelteobagrus vachelli muscle. Mol Cell Proteomics 2022;:100196. [PMID: 35031490 DOI: 10.1016/j.mcpro.2022.100196] [Reference Citation Analysis]
3 Pan M, Wang Q, Cheng T, Wu D, Wang T, Yan G, Shao J. Paeonol assists fluconazole and amphotericin B to inhibit virulence factors and pathogenicity of Candida albicans. Biofouling 2021;37:922-37. [PMID: 34615415 DOI: 10.1080/08927014.2021.1985473] [Reference Citation Analysis]
4 Wu M, Yu Z, Li X, Zhang X, Wang S, Yang S, Hu L, Liu L. Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview. Front Cardiovasc Med 2021;8:690116. [PMID: 34368250 DOI: 10.3389/fcvm.2021.690116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]